- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Stapled Peptides as Inhibitors of mRNA Deadenylation ; day:06 ; month:11 ; year:2024 ; extent:11
Angewandte Chemie / International edition. International edition ; (06.11.2024) (gesamt 11)
- Creator
-
Pal, Sunit
Gordijenko, Ilja
Schmeing, Stefan
Biswas, Somarghya
Akbulut, Yasemin
Gasper, Raphael
't Hart, Peter
- DOI
-
10.1002/anie.202413911
- URN
-
urn:nbn:de:101:1-2411061407378.742544715981
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pal, Sunit
- Gordijenko, Ilja
- Schmeing, Stefan
- Biswas, Somarghya
- Akbulut, Yasemin
- Gasper, Raphael
- 't Hart, Peter
Other Objects (12)
Stapled Peptides as Inhibitors of mRNA Deadenylation
Targeting RNA-Protein interactions with peptides and small molecule inhibitors
A novel mRNA decay inhibitor abolishes pathophysiological cellular transition
Peptides targeting caspase inhibitors
N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA
mRNA as novel technology for passive immunotherapy
RNA-controlled nucleocytoplasmic shuttling of mRNA decay factors regulates mRNA synthesis and a novel mRNA decay pathway
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Kreuzimpfungen mit mRNA
Quantifizierung nativer mRNA
Synthetic mRNA capping
Stapled Peptides as Inhibitors of mRNA Deadenylation
Targeting RNA-Protein interactions with peptides and small molecule inhibitors
A novel mRNA decay inhibitor abolishes pathophysiological cellular transition
Peptides targeting caspase inhibitors
N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA
mRNA as novel technology for passive immunotherapy
RNA-controlled nucleocytoplasmic shuttling of mRNA decay factors regulates mRNA synthesis and a novel mRNA decay pathway
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Kreuzimpfungen mit mRNA
Quantifizierung nativer mRNA
Synthetic mRNA capping
Stapled Peptides as Inhibitors of mRNA Deadenylation
Targeting RNA-Protein interactions with peptides and small molecule inhibitors
A novel mRNA decay inhibitor abolishes pathophysiological cellular transition
Peptides targeting caspase inhibitors
N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA
mRNA as novel technology for passive immunotherapy
RNA-controlled nucleocytoplasmic shuttling of mRNA decay factors regulates mRNA synthesis and a novel mRNA decay pathway
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Kreuzimpfungen mit mRNA
Quantifizierung nativer mRNA